ÂÜÀòÂÒÂ×

Mark Hopman, R.Ph, MBA has extensive work experience in the pharmaceutical and healthcare industry. Mark has held various leadership roles throughout their career.

From 2001 to 2004, Hopman worked at Kroger as a Pharmacy Intern, Pharmacist, and eventually a Pharmacy Manager. During this time, they gained experience in the retail pharmacy setting and managed the highest volume pharmacy in the Kroger Enterprise.

In 2004, Hopman joined Kroger Anderson as a Pharmacy Manager and Pharmacy Clinical Site Manager. In this role, they successfully increased script count and revenue, developed and led a team of employees, and fostered relationships with healthcare professionals and drug representatives.

In 2009, Hopman transitioned to a role as the Clinical Program Manager for Kroger Prescription Plans, where they were responsible for managing various wellness products and leading a national sales team. Mark achieved significant success in the 2013 RFP season, resulting in a high win rate and increased revenue generation.

In 2014, Hopman joined Dexcom as a Director, Retail Distribution - US, and later became the Senior Director of Trade. In these roles, they were responsible for delivering pharmacy and distributor-based product sales, as well as international sales for clinical trials. Mark led a team of account executives and developed strong relationships with distributors, wholesalers, and retailers.

Hopman's most recent role, starting in 2021, is with Pear Therapeutics as the Vice President of Market Access. Here, they played a key role in market access strategies and initiatives.

Currently, Hopman holds the position of SVP, Market Access at Beta Bionics, where they continue to contribute their expertise in the field.

Mark Hopman, R.Ph, MBA attended the Rose-Hulman Institute of Technology from 1996 to 1998, where they pursued a field of study in Chemical Engineering. Following that, they enrolled at The Ohio State University College of Pharmacy from 1999 to 2001, earning a Bachelor of Science in Pharmacy (B.S. Pharmacy). Mark later pursued their Master of Business Administration (MBA) degree at Xavier University - Williams College of Business, completing their studies from 2011 to 2013.